SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVerici Dx Regulatory News (VRCI)

Share Price Information for Verici Dx (VRCI)

Share Price is delayed by 15 minutes
Get Live Data
0.375    0.00 (0.00%)
Bid:
0.35
Ask:
0.40
Spread: 0.05 (14.286%)
Market Cap: £8.30m
VRCI Live PriceLast checked at - London Stock Exchange

Intraday Verici Dx Share Chart

Date   Source Headline
28th Mar 202311:05 amRNSSecond Price Monitoring Extn
28th Mar 202311:00 amRNSPrice Monitoring Extension
28th Mar 20239:05 amRNSSecond Price Monitoring Extn
28th Mar 20239:00 amRNSPrice Monitoring Extension
27th Mar 20234:35 pmRNSPrice Monitoring Extension
27th Mar 202311:05 amRNSSecond Price Monitoring Extn
27th Mar 202311:00 amRNSPrice Monitoring Extension
22nd Mar 20237:00 amRNSOperational Update
21st Mar 20234:40 pmRNSSecond Price Monitoring Extn
21st Mar 20234:35 pmRNSPrice Monitoring Extension
13th Mar 20237:00 amRNSStatement re. Silicon Valley Bank
9th Mar 20237:00 amRNSTwo key patents granted in the US
2nd Mar 20237:00 amRNSCLIA Certificate of Compliance
27th Feb 20232:00 pmRNSPrice Monitoring Extension
7th Dec 20227:00 amRNSDirector/PDMR Shareholding
1st Dec 20226:07 pmRNSCorrection: Holding(s) in Company
3rd Oct 20227:00 amRNSProduct rebranding as Tutivia™
7th Sep 20227:00 amRNSHalf-year Report
6th Sep 20227:00 amRNSPositive results for Clarava from validation study
5th Sep 20227:00 amRNSNotice of Results
2nd Sep 20224:41 pmRNSSecond Price Monitoring Extn
2nd Sep 20224:35 pmRNSPrice Monitoring Extension
27th Jun 20223:17 pmRNSResult of AGM and voting results
24th Jun 20227:00 amRNSHolding(s) in Company
20th Jun 20227:30 amRNSDistribution of Verici Dx shares by EKF
16th Jun 20227:00 amRNSInvestor Presentation
15th Jun 202210:57 amRNSCEO Video Interview
14th Jun 20229:00 amRNSFurther data from Tuteva™ validation study
9th Jun 20227:00 amRNSCommercial Team Appointments
25th May 202212:00 pmRNSPosting of Annual Report & Accounts
19th May 20227:00 amRNSFinal Results
12th May 20227:00 amRNSResults of Tuteva™ clinical validation study
1st Apr 20227:00 amRNSClinical Validation Study Update
23rd Mar 20226:12 pmRNSHolding(s) in Company
21st Mar 20227:00 amRNSHolding(s) in Company
18th Mar 20225:13 pmRNSHolding(s) in Company
16th Mar 20223:33 pmRNSHolding(s) in Company
15th Mar 20224:34 pmRNSHolding(s) in Company
11th Mar 20229:30 amRNSClose of Subscription and Fundraise Update
4th Mar 20224:13 pmRNSResult of Fundraise
4th Mar 202212:20 pmRNSClose of Accelerated Bookbuild
4th Mar 20227:10 amRNSProposed Fundraise
15th Feb 20227:00 amRNSSuccessful completion of analytical validation
26th Jan 20224:28 pmRNSNet Asset Value(s)
14th Jan 20227:00 amRNSInvestor Presentation
12th Jan 20222:00 pmRNSProgress and strategy update
6th Jan 20227:00 amRNSClarava™ and Tuteva™ complete testing requirements
5th Jan 20227:00 amRNSCollaboration with Illumina
4th Jan 20227:00 amRNSGrant of two CPT Codes by AMA
17th Dec 20211:19 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.